Krka Logo

Krka

An international generic pharmaceutical company developing human and animal health products.

KRKG | LJSE

Overview

Corporate Details

ISIN(s):
SI0031102120
LEI:
549300H9RLRTRTLRUZ73
Country:
Slovenia
Address:
Šmarješka cesta 006, 8501 Novo mesto

Description

Krka is an international generic pharmaceutical company engaged in the development, production, marketing, and sales of human and animal health products. The company's core business is focused on generic prescription pharmaceuticals, which it markets under its own brands. Its product portfolio is complemented by a range of non-prescription products and a comprehensive line of animal health products. With a history spanning over 70 years, Krka is committed to providing high-quality, effective, and safe products to a global market, aiming to contribute to a better quality of life.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-04-15 08:30
2021 Supervisory Board Report of Krka, d. d., Novo mesto
English 447.6 KB
2022-04-15 08:30
2021 Supervisory Board Report of Krka, d. d., Novo mesto
English 1.1 KB
2022-04-15 08:30
Poročilo nadzornega sveta Krke za leto 2021
Slovene 339.2 KB
2022-04-15 08:30
Poročilo nadzornega sveta Krke za leto 2021
Slovene 1.0 KB
2022-04-15 08:30
Audited consolidated and unconsolidated annual report for the year 2021
English 15.8 MB
2022-04-15 08:30
Audited consolidated and unconsolidated annual report of company Krka, d. d., N…
English 1.7 KB
2022-04-15 08:30
Revidirano letno konsolidirano in nekonsolidirano poročilo za leto 2021
Slovene 13.1 MB
2022-04-15 08:30
Revidirano letno konsolidirano in nekonsolidirano poročilo družbe Krka, d. d., …
Slovene 1.7 KB
2022-04-14 08:29
Krka Supervisory Board Report 2021
English 447.6 KB
2022-04-14 08:18
Annual report 2021 _ESEF_
Polish 15.8 MB
2022-04-08 08:30
Proposed dividend for Krka shareholders
English 75.8 KB
2022-04-08 08:30
Proposed dividend for Krka shareholders 12.6% higher than last year
English 1.1 KB
2022-04-08 08:30
Predlagana dividenda za Krkine delničarje
Slovene 88.0 KB
2022-04-08 08:30
Predlagana dividenda za Krkine delničarje 12,6 % višja od lanske
Slovene 1.4 KB
2022-04-07 08:16
Proposed dividend for Krka shareholders
English 75.8 KB

Automate Your Workflow. Get a real-time feed of all Krka filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Krka

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Krka via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.